Continuous Glucose Monitoring (CGM) for Quality of Life (QOL)? Shaking My Head or Of Course?

Moderator:
Abigail Klutts, PharmD
Panelists:
Diana Isaacs, PharmD, BCPS, BC-ADM, BCACP, CDE
T. Joey Mattingly, PharmD, MBA, PhD
Reviewed By:
Erin Vanmeter, PharmD, BCACP
Kathleen (Katy) Pincus, PharmD, BCPS, BCACP
Citation:
Fokkert M, van Dijk P, Edens M, et al   Improved well-being and decreased disease burden after 1-year use of flash glucose monitoring (FLARE-NL4)BMJ Open Diabetes Research and Care 2019;7:e000809. doi: 10.1136/bmjdrc-2019-000809

In this vidcast, Abigail Klutts presents the methods and results of the FLARE-NL4 study and speaks with Diana Isaacs and T. Joey Mattingly about the strengths, limitations, and application of these findings to practice.

Here are hyperlinks to the SF-12, EQ-5D-3L and DVN-PROMS.